Trials / Recruiting
RecruitingNCT03392337
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Psoriasis Treatment Center of Central New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of response.
Detailed description
30 subjects will be treated with increasing doses of Narrowband Ultraviolet phototherapy three times weekly for 12 weeks. Patients will then be evaluated every 6 weeks through week 36 to determine maintenance of response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Narrowband UVB phototherapy | Ultraviolet B phototherapy |
Timeline
- Start date
- 2017-11-07
- Primary completion
- 2019-12-01
- Completion
- 2020-01-01
- First posted
- 2018-01-05
- Last updated
- 2019-01-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03392337. Inclusion in this directory is not an endorsement.